Trial Profile
Higher Risk of Kidney Function Decline With Entecavir Than Tenofovir Alafenamide in Patients With HBV Related Acute-on-chronic Liver Failure: Real-World Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2022
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir alafenamide (Primary)
- Indications Hepatitis B; Liver failure
- Focus Therapeutic Use
- 15 Jul 2022 New trial record